Commutability of external quality assessment materials for point‐of‐care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches

The aim of this study was to assess the commutability of three external quality assessment (EQA) materials for point‐of‐care (POC) glucose testing using two approaches, to identify suitable EQA materials to evaluate and monitor the quality of POC testing.

[1]  N. G. Christensen,et al.  Commutability of a Whole-Blood External Quality Assessment Material for Point-of-Care C-Reactive Protein, Glucose, and Hemoglobin Testing. , 2019, Clinical chemistry.

[2]  M. Panteghini,et al.  Commutability of reference and control materials: an essential factor for assuring the quality of measurements in Laboratory Medicine , 2019, Clinical chemistry and laboratory medicine.

[3]  Donghuang Wang,et al.  Commutability of external quality assessment materials for serum sodium and potassium measurements , 2018, Clinical chemistry and laboratory medicine.

[4]  I. Zegers,et al.  Commutability Assessment of Candidate Reference Materials for Pancreatic α-Amylase. , 2018, Clinical chemistry.

[5]  Frank Klawonn,et al.  External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impact , 2018, Clinical chemistry and laboratory medicine.

[6]  Johanna E. Camara,et al.  IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical Samples. , 2018, Clinical chemistry.

[7]  Göran Nilsson,et al.  IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design. , 2018, Clinical chemistry.

[8]  Shunli Zhang,et al.  Commutability of Reference Materials for α-Fetoprotein in Human Serum. , 2017, Archives of pathology & laboratory medicine.

[9]  Laya Ekhlaspour,et al.  Comparative Accuracy of 17 Point-of-Care Glucose Meters , 2017, Journal of diabetes science and technology.

[10]  Julie Jacobs,et al.  A further cautionary tale for interpretation of external quality assurance results (EQA): Commutability of EQA materials for point-of-care glucose meters. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[11]  Guido Freckmann,et al.  Interferences and Limitations in Blood Glucose Self-Testing , 2016, Journal of diabetes science and technology.

[12]  B. Aslan,et al.  Method precision and frequent causes of errors observed in point-of-care glucose testing: a proficiency testing program perspective. , 2014, American journal of clinical pathology.

[13]  Wenxiang Chen,et al.  Commutability of Possible External Quality Assessment Materials for Cardiac Troponin Measurement , 2014, PloS one.

[14]  Matthias Appel,et al.  Application of the Reference Method Isotope Dilution Gas Chromatography Mass Spectrometry (ID/GC/MS) to Establish Metrological Traceability for Calibration and Control of Blood Glucose Test Systems , 2014, Journal of diabetes science and technology.

[15]  G. Banfi,et al.  Point-of-care testing: where is the evidence? A systematic survey , 2013, Clinical chemistry and laboratory medicine.

[16]  Fred S Apple,et al.  Analytical characteristics of high-sensitivity cardiac troponin assays. , 2012, Clinical chemistry.

[17]  Cas Weykamp,et al.  Proficiency testing/external quality assessment: current challenges and future directions. , 2011, Clinical chemistry.

[18]  K. Lewandrowski,et al.  Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. , 2011, Archives of pathology & laboratory medicine.

[19]  Boyd,et al.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. , 2002, Clinical chemistry.

[20]  K. Lewandrowski,et al.  Point of care testing in a large urban academic medical center: evolving test menu and clinical applications. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[21]  Sverre Sandberg,et al.  Self-monitoring of blood glucose with a focus on analytical quality: an overview , 2010, Clinical chemistry and laboratory medicine.

[22]  Emons Hendrik,et al.  Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine - Approved Guideline , 2010 .

[23]  Thomas G Schleis,et al.  Interference of Maltose, Icodextrin, Galactose, or Xylose with Some Blood Glucose Monitoring Systems , 2007, Pharmacotherapy.

[24]  William Graham Wood.  Problems and Practical Solutions in the External Quality Control of Point of Care Devices with Respect to the Measurement of Blood Glucose , 2007, Journal of diabetes science and technology.

[25]  Martin H Kroll,et al.  The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. , 2006, Archives of pathology & laboratory medicine.

[26]  James H Nichols,et al.  Performance evaluation of blood glucose monitoring devices. , 2003, Diabetes technology & therapeutics.

[27]  D. Freedman.  Clinical governance: implications for point-of-care testing , 2002, Annals of clinical biochemistry.

[28]  S Sandberg,et al.  Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. , 2001, Clinical chemistry.

[29]  P. St-Louis.  Status of point-of-care testing: promise, realities, and possibilities. , 2000, Clinical biochemistry.